Cargando…

A review on recent advances on nobiletin in central and peripheral nervous system diseases

In recent years, the role of nobiletin in neuronal disorders has received extensive attention. However, the study of nobiletin in the peripheral nervous system is limited. Nobiletin, as a compound with high fat solubility, high bioavailability and low toxicity, has been extensively studied. Accumula...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Yueshan, Xiong, Juan, Wu, You, Ding, Weijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626649/
https://www.ncbi.nlm.nih.gov/pubmed/37932838
http://dx.doi.org/10.1186/s40001-023-01450-7
_version_ 1785131379304955904
author Pang, Yueshan
Xiong, Juan
Wu, You
Ding, Weijun
author_facet Pang, Yueshan
Xiong, Juan
Wu, You
Ding, Weijun
author_sort Pang, Yueshan
collection PubMed
description In recent years, the role of nobiletin in neuronal disorders has received extensive attention. However, the study of nobiletin in the peripheral nervous system is limited. Nobiletin, as a compound with high fat solubility, high bioavailability and low toxicity, has been extensively studied. Accumulating scientific evidence has shown that nobiletin has a variety of biological functions in the nervous system, such as inhibiting the expression of inflammatory factors, reducing the neurotoxic response, improving the antioxidant capacity, promoting the survival of nerve cells, promoting axon growth, reducing blood‒brain barrier permeability, reducing brain oedema, promoting cAMP response element binding protein expression, improving memory, and promoting mild depolarization of nerve cell mitochondria to improve antioxidative stress capacity. Accumulating studies have shown that nobiletin also protects enteric nervous system, spinal cord and sciatic nerve. To explore the new therapeutic potential of nobiletin in the nervous system, recent and relevant research progress is reviewed in this article. This will provide a new research idea for nobiletin in the nervous system.
format Online
Article
Text
id pubmed-10626649
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106266492023-11-07 A review on recent advances on nobiletin in central and peripheral nervous system diseases Pang, Yueshan Xiong, Juan Wu, You Ding, Weijun Eur J Med Res Research In recent years, the role of nobiletin in neuronal disorders has received extensive attention. However, the study of nobiletin in the peripheral nervous system is limited. Nobiletin, as a compound with high fat solubility, high bioavailability and low toxicity, has been extensively studied. Accumulating scientific evidence has shown that nobiletin has a variety of biological functions in the nervous system, such as inhibiting the expression of inflammatory factors, reducing the neurotoxic response, improving the antioxidant capacity, promoting the survival of nerve cells, promoting axon growth, reducing blood‒brain barrier permeability, reducing brain oedema, promoting cAMP response element binding protein expression, improving memory, and promoting mild depolarization of nerve cell mitochondria to improve antioxidative stress capacity. Accumulating studies have shown that nobiletin also protects enteric nervous system, spinal cord and sciatic nerve. To explore the new therapeutic potential of nobiletin in the nervous system, recent and relevant research progress is reviewed in this article. This will provide a new research idea for nobiletin in the nervous system. BioMed Central 2023-11-06 /pmc/articles/PMC10626649/ /pubmed/37932838 http://dx.doi.org/10.1186/s40001-023-01450-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pang, Yueshan
Xiong, Juan
Wu, You
Ding, Weijun
A review on recent advances on nobiletin in central and peripheral nervous system diseases
title A review on recent advances on nobiletin in central and peripheral nervous system diseases
title_full A review on recent advances on nobiletin in central and peripheral nervous system diseases
title_fullStr A review on recent advances on nobiletin in central and peripheral nervous system diseases
title_full_unstemmed A review on recent advances on nobiletin in central and peripheral nervous system diseases
title_short A review on recent advances on nobiletin in central and peripheral nervous system diseases
title_sort review on recent advances on nobiletin in central and peripheral nervous system diseases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626649/
https://www.ncbi.nlm.nih.gov/pubmed/37932838
http://dx.doi.org/10.1186/s40001-023-01450-7
work_keys_str_mv AT pangyueshan areviewonrecentadvancesonnobiletinincentralandperipheralnervoussystemdiseases
AT xiongjuan areviewonrecentadvancesonnobiletinincentralandperipheralnervoussystemdiseases
AT wuyou areviewonrecentadvancesonnobiletinincentralandperipheralnervoussystemdiseases
AT dingweijun areviewonrecentadvancesonnobiletinincentralandperipheralnervoussystemdiseases
AT pangyueshan reviewonrecentadvancesonnobiletinincentralandperipheralnervoussystemdiseases
AT xiongjuan reviewonrecentadvancesonnobiletinincentralandperipheralnervoussystemdiseases
AT wuyou reviewonrecentadvancesonnobiletinincentralandperipheralnervoussystemdiseases
AT dingweijun reviewonrecentadvancesonnobiletinincentralandperipheralnervoussystemdiseases